World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
150
Citations
75535
World Ranking
1166
National Ranking
675

Overview

Neal S. Young is affiliated with the National Institutes of Health in the United States. Their research predominantly spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Specialized subfields include Hematology, Immunology, Genetics, Molecular Biology, and Rheumatology.

The scientist's publication record indicates substantial contributions to topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Otitis Media and Relapsing Polychondritis, Immune Cell Function and Interaction, Immunodeficiency and Autoimmune Disorders, Single-cell and spatial transcriptomics, and Cancer Genomics and Diagnostics.

Neal S. Young has been published frequently in several venues, including:

  • Blood
  • Blood Advances
  • British Journal of Haematology
  • Haematologica
  • Leukemia

Significant recent papers authored or co-authored by Neal S. Young include:

  • Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease, 2020, New England Journal of Medicine
  • Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS, 2021, Arthritis & Rheumatology
  • Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1, 2021, Blood Advances
  • Somatic Mutations in "Benign" Disease, 2021, New England Journal of Medicine
  • Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis, 2022, Blood

Frequent co-authors of Neal S. Young include Bhavisha A. Patel, Emma M. Groarke, Zhijie Wu, Xingmin Feng, and Fernanda Gutierrez-Rodrigues.

Best Publications

  • The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Neal S. Young;Jörg Schubert;Robert A. Brodsky

  • Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

    Childs R;Chernoff A;Contentin N;Bahceci E

  • Current concepts in the pathophysiology and treatment of aplastic anemia

    Neal S. Young;Rodrigo T. Calado;Phillip Scheinberg

  • Erythrocyte P antigen: cellular receptor for B19 parvovirus

    Kevin E. Brown;Stacie M. Anderson;Neal S. Young

  • Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.

    David B. Beck;Marcela A. Ferrada;Keith A. Sikora;Amanda K. Ombrello

  • Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

    Charles Parker;Mitsuhiro Omine;Stephen Richards;Jun-Ichi Nishimura

  • Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

    Gary M. Brittenham;Patricia M. Griffith;Arthur W. Nienhuis;Christine E. McLaren

  • Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.

    Hiroki Yamaguchi;Rodrigo T. Calado;Hinh Ly;Sachiko Kajigaya

  • Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

    Robert A. Brodsky;Neal S. Young;Elisabetta Antonioli;Antonio M. Risitano

  • Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Petra Muus;Ulrich Dührsen;Antonio M. Risitano

  • The pathophysiology of acquired aplastic anemia.

    Neal S. Young;Jaroslaw Maciejewski

  • Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

    R. Childs;E. Clave;N. Contentin;D. Jayasekera

  • Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia

    Tetsuichi Yoshizato;Bogdan Dumitriu;Kohei Hosokawa;Hideki Makishima

  • 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.

    Ley Tj;DeSimone J;Anagnou Np;Keller Gh

  • Why current publication practices may distort science.

    Neal S Young;John P. A Ioannidis;Omar Al-Ubaydli

  • Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

    Norbert Frickhofen;Janis L. Abkowitz;Monika Safford;J. Michael Berry

  • Acquired Aplastic Anemia

    Neal S. Young

  • Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.

    Gary Kurtzman;Norbert Frickhofen;Janice Kimball;Douglas W. Jenkins

  • Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia

    Matthew J. Olnes;Phillip Scheinberg;Katherine R. Calvo;Ronan Desmond

  • Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.

    R. V. B. Emmons;D. M. Reid;R. L. Cohen;G. Meng

Frequent Co-Authors

Sachiko Kajigaya
Sachiko Kajigaya National Institutes of Health
Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski Cleveland Clinic
Cynthia E. Dunbar
Cynthia E. Dunbar National Institutes of Health
A. John Barrett
A. John Barrett National Institutes of Health
J. Philip McCoy
J. Philip McCoy National Institutes of Health
Richard Childs
Richard Childs National Institutes of Health
Peter M. Lansdorp
Peter M. Lansdorp University of British Columbia
Stacie M. Anderson
Stacie M. Anderson National Institutes of Health
Susan F. Leitman
Susan F. Leitman National Institutes of Health
Peter Hillmen
Peter Hillmen St James's University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and supporting healthcare careers can open rewarding opportunities for students interested in medicine. For those without a nursing background looking to fast-track their entry into advanced nursing roles, there are online MSN programs for non nurses that offer flexible, accelerated paths to a master's degree.

If you’re seeking accessible programs, some nursing schools with high acceptance rates make admission more attainable—ideal for those transitioning to nursing from another field. Additionally, online medical billing and coding with financial aid provides an opportunity to quickly enter the growing administrative side of healthcare.

For students specifically interested in nursing programs that minimize admissions testing, consider ABSN programs that don't require TEAS or similar entrance exams. These alternatives expand access to healthcare education and can serve as stepping stones toward a future in medicine or related fields.

Best Scientists Citing Neal S. Young

Trending Scientists